Jean L.J.M. Scheijen
- Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research 59
-
- Diet, Metabolism, and Disease 11
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Natural Antidiabetic Agents Studies 8
- Biochemistry top 5%
-
- Alcohol Consumption and Health Effects 14
- Nephrology top 5%
-
- Fatty Acid Research and Health 9
-
- Biochemical effects in animals 7
- Diet and metabolism studies 6
- Co-authors
- Casper G. SchalkwijkCoen D.A. StehouwerNordin M.J. HanssenMarleen M. J. van GreevenbroekLian EngelenCarla KallenPieter C. DagnelieFred Brouns
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Jean L.J.M. Scheijen
79 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 111
- Clinical Biochemistry 1.8k
- Endocrinology, Diabetes and Metabolism 942
- Biochemistry 159
- Pathology and Forensic Medicine 457
- Nephrology 156
Countries citing papers authored by Jean L.J.M. Scheijen
This map shows the geographic impact of Jean L.J.M. Scheijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean L.J.M. Scheijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean L.J.M. Scheijen more than expected).
Fields of papers citing papers by Jean L.J.M. Scheijen
This network shows the impact of papers produced by Jean L.J.M. Scheijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean L.J.M. Scheijen. The network helps show where Jean L.J.M. Scheijen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean L.J.M. Scheijen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 24 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 99 | |
| 14 | 2019 | 22 | |
| 15 | 2015 | 40 | |
| 16 | 2014 | 36 | |
| 17 | 2013 | 136 | |
| 18 | Plasma advanced glycation end products are not associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies | 2012 | 1 |
| 19 | Clinical and prognostic value of advanced glycation end-products (AGEs) in chronic heart failure | 2007 | 1 |
| 20 | Abstract 2389: Clinical and Prognostic Value of Advanced Glycation End-products (AGEs) in Chronic Heart Failure | 2007 | 2 |
About Jean L.J.M. Scheijen
Jean L.J.M. Scheijen is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics, having authored 80 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (59 papers), Alcohol Consumption and Health Effects (14 papers), Diet, Metabolism, and Disease (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Fatty Acid Research and Health (9 papers), Natural Antidiabetic Agents Studies (8 papers), Biochemical effects in animals (7 papers) and Diet and metabolism studies (6 papers). The work is most often cited by research in Clinical Biochemistry (1.8k citations), Endocrinology, Diabetes and Metabolism (942 citations) and Biochemistry (159 citations). Jean L.J.M. Scheijen has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Casper G. Schalkwijk, Coen D.A. Stehouwer, Nordin M.J. Hanssen, Marleen M. J. van Greevenbroek, Lian Engelen, Carla Kallen, Pieter C. Dagnelie, Fred Brouns, Marjo P. H. van de Waarenburg and Egbert Clevers. Their work appears in journals such as Diabetes Care, Scientific Reports, Diabetes, American Journal of Clinical Nutrition and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.